REQUEST A DEMO
Total
USD $0.00
Search more companies

PHARMATEKA Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: PHARMATEKA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

PHARMATEKA Kft. is based in Hungary, with the head office in Pusztaberki. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on April 07, 2008. PHARMATEKA Kft. currently employs 4 (2024) people. The company’s latest financial report indicates a net sales revenue increase of 18.27% in 2024. Its’ total assets recorded a negative growth of 27.35%. The net profit margin of PHARMATEKA Kft. decreased by 1.11% in 2024.

Headquarters
Kossuth utca 20.
Pusztaberki; Nograd; Postal Code: 2658

Contact Details: Purchase the PHARMATEKA Kft. report to view the information.

Website: http://www.pharmateka.hu

Basic Information
Total Employees:
Purchase the PHARMATEKA Kft. report to view the information.
Registered Capital:
Purchase the PHARMATEKA Kft. report to view the information.
Financial Auditors:
Purchase the PHARMATEKA Kft. report to view the information.
Incorporation Date:
April 07, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PHARMATEKA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
18.27%
Total operating revenue
14.62%
Operating profit (EBIT)
-43.18%
EBITDA
-16529.41%
Net Profit (Loss) for the Period
-57.78%
Total Assets
-27.35%
Total Equity
-12.82%
Operating Profit Margin (ROS)
-0.54%
Net Profit Margin
-1.11%
Return on Equity (ROE)
-6.58%
Quick Ratio
0.27%
Cash Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?